CHELSEA MORRISON: Open Payments
NPI 1639746365 · ESTILL SPRINGS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$897 in 37 payments from 11 companies in 2025. Trend: 2023 $336 · 2024 $689 · 2025 $897
Food & beverage: $897
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 8 | $271 |
| Vanda Pharmaceuticals Inc. | 6 | $146 |
| Teva Pharmaceuticals USA, Inc. | 6 | $135 |
| Neurocrine BioSciences, Inc. | 5 | $110 |
| ABBVIE INC. | 4 | $69 |
| Janssen Pharmaceuticals, Inc | 2 | $47 |
| Tris Pharma Inc | 2 | $34 |
| Supernus Pharmaceuticals, Inc. | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Corium, LLC | 1 | $20 |
Products named: LYBALVI, FANAPT, INGREZZA, UZEDY, ARISTADA, VRAYLAR, INVEGA SUSTENNA, AUSTEDO XR.
Industry payments across TN — which companies pay providers there.
